Advertisement

Topics

Affibody Company Profile

23:41 EST 18th November 2017 | BioPortfolio

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file one targeted therapeutics IND every second year.

Location

Voltavägen 13,floor 5
Bromma
SE-168 69
Sweden

Contact

Phone: 46 (0) 8 598 838 00
Fax: 46 (0) 8 598 838 01
Email: reception@affibody.com


News Articles [2 Associated News Articles listed on BioPortfolio]

Beyond antibodies. Are Affibody poised to make the next significant biologics breakthrough?

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. During NLSD in...

Affibody AB Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAffibody AB Affibody is a biotechnology company that focuses on the development of next generation biopharmaceuticals based on its proprietary technology platforms, namely, Affibody molecules a...

Drugs and Medications [0 Results]

None

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Insights from engineering the Affibody-Fc interaction with a computational-experimental method.

The interaction between the Staphylococcal Protein A (SpA) domain B (the basis of the Affibody) molecule and the Fc of IgG is key to the use of Affibodies in affinity chromatography and in potential t...

Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.

Ferritin nanocages are of particular interest as a novel platform for drug and vaccine delivery, diagnosis, biomineralization scaffold and more, due to their perfect and complex symmetry, ideal physic...

Monodisperse Au-Fe2C Janus Nanoparticles: an Attractive Multifunctional Material for Triple-Modal Imaging-Guided Tumor Photothermal Therapy.

Imaging-guided photothermal therapy (PTT) by combination of imaging and PTT together has been emerging as a promising therapeutic method for precision therapy. However, the development of multicompone...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

In Vivo IGF-1R Molecular Imaging Using [68Ga]- Labelling Anti-IGF-1R Affibody Molecule

The investigators developed [68Ga]-labelling Anti-IGF-1R Affibody Molecule as a targeted molecular imaging agent for noninvasive and repeatable detecting IGF-1R expression status.

In Vivo EGFR-ECD Molecular Imaging Using [68Ga]- Labelling Anti-EGFR Affibody Molecule

The investigators developed [68Ga]-labelling Anti-EGFR Affibody Molecule as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-ECD expression status.

Companies [1 Associated Companies listed on BioPortfolio]

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has ...

More Information about "Affibody" on BioPortfolio

We have published hundreds of Affibody news stories on BioPortfolio along with dozens of Affibody Clinical Trials and PubMed Articles about Affibody for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Affibody Companies in our database. You can also find out about relevant Affibody Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record